PTC Therapeutics

PTCT

PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.In September 2009, PTC entered into an agreement with R …

Insider trades and stock quote 2022-2024

All insider trades at PTC Therapeutics

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
1/30/2024 SellUtter, Christine Marie SVP, CHIEF ACCOUNTING OFFICER $27.3 $8,666
1/30/2024 SellPauwels, Eric CHIEF BUSINESS OFFICER $27.3 $9,974
1/30/2024 SellBoulding, Mark Elliott EXEC. VP AND CLO $27.3 $21,637
1/30/2024 SellAlmstead, Neil Gregory CHIEF TECHNICAL OPS OFFICER $27.3 $17,604
1/22/2024 SellJacobson, Allan Steven Director $27.4 $273,804
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)